International Journal of Hematology

DOI: 10.1007/s12185-011-0857-0 Pages: 11-23

Polycomb group proteins in hematopoietic stem cell aging and malignancies

1. University of Groningen, Department of Cell Biology, Section of Stem Cell Biology, University Medical Center Groningen

2. European Research Institute on the Biology of Ageing (ERIBA)

Correspondence to:
Gerald Haan
Tel: +31-50-3632722



Protection of the transcriptional “stemness” network is important to maintain a healthy hematopoietic stem cells (HSCs) compartment during the lifetime of the organism. Recent evidence shows that fundamental changes in the epigenetic status of HSCs might be one of the driving forces behind many age-related HSC changes and might pave the way for HSC malignant transformation and subsequent leukemia development, the incidence of which increases exponentially with age. Polycomb group (PcG) proteins are key epigenetic regulators of HSC cellular fate decisions and are often found to be misregulated in human hematopoietic malignancies. In this review, we speculate that PcG proteins balance HSC aging against the risk of developing cancer, since a disturbance in PcG genes and proteins affects several important cellular processes such as cell fate decisions, senescence, apoptosis, and DNA damage repair.

To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge